跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atorvast-Natrapharm - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Atorvast-Natrapharm
Approved
STANDARD
Atorvast-Natrapharm
Apotex Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6c6670fd07634dce
Company
Apotex Inc.
Type
Standard
Approval Details
Approval Id
6c6670fd07634dce
Drug Approval Philippines Name
Atorvast-Natrapharm
Product Name
Atorvast-Natrapharm
Registration Number
DR-XY40119
Brand Name
Atorvast-Natrapharm
Generic Name
Atorvastatin (As Calcium Propylene Glycol Solvate)
Dosage Form
Film-Coated Tablet
Dosage Strength
80mg
Manufacturer
Apotex Inc.
Importer
Natrapharm Inc.
Company Detail Path
/organization/apotex-inc
Issuance Date
26 April 2024
Expiry Date
04 October 2029
Pharmacologic Category
Antihyperlipidemic (HMG CoA reductase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6c6670fd07634dce
Type
Standard
Back to Philippines FDA Approvals